Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Moderna earned $5.4 billion in U.S. revenues in 2021 and $4.4 billion in 2022 from COVID-19 vaccine sales. Northwestern University’s nanotechnology research institute, IIN, has supported over $2 ...

And it's caused by one simple fact: the human brain, that most sensitive of organs, is under threat from the modern world ... a future in which neuro-chip technology blurs the line between ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna (MRNA) closed the latest trading day at $55.22, indicating a +0.77% change from the previous session's end. This change outpaced the S&P 500's 0.16% gain on the day. Meanwhile, the Dow ...

Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences: ...

Friedberg is a former investment portfolio manager, university finance instructor and author of three books including "Personal Finance; An Encyclopedia of Modern Money Management." Her work has ...

Astrology is evolving with AI, making personalized horoscopes accessible through apps. AI analyzes intricate birth charts and ...

A link exists between 6,000-year-old engravings on cylindrical seals used on clay tablets and cuneiform, the world’s oldest ...

The video shows a modern take on traditional Diwali celebrations ... Social media users are thrilled by this combination of ...